Gideon A. Rodan

Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure.

Masahiko Sato, W A Grasser, Naoto Endo et al. · Journal of Clinical Investigation · 1991 · 1K citations · Full text

Medicine, Endocrinology, Bone Augmentation +14

Interleukin‐6 deficient mice are protected from bone loss caused by estrogen depletion.

Valeria Poli, R. Balena, Elena Fattori et al. · The EMBO Journal · 1994 · 753 citations · Full text

Medicine, Endocrinology, Immunology +16

Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation <i>in vitro</i>

John Fisher, Michael J. Rogers, J. M. Halasy et al. · Proceedings of the National Academy of Sciences · 1999 · 679 citations

Medicine, Biochemistry, Pharmacology +17

Characterization of articular cartilage and subchondral bone changes in the rat anterior cruciate ligament transection and meniscectomized models of osteoarthritis

Tadashi Hayami, Maureen Pickarski, Ya Zhuo et al. · Bone · 2005 · 627 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17

Characterization of a human osteosarcoma cell line (Saos-2) with osteoblastic properties.

Sevgi B. Rodan, Yasuo Imai, Mark A. Thiede et al. · PubMed · 1987 · 594 citations

Medicine, Cell Biology, Bone Metabolism +14